期刊文献+

大肠癌组织中Galectin-3的表达及临床意义 被引量:3

The Expression and Clinical Significance of Galectin-3 in Human Colorectal Carcinoma
在线阅读 下载PDF
导出
摘要 目的:研究半乳糖凝集素-3(Galectin-3)在大肠癌中的表达,并探讨其在大肠癌进展过程中的意义,旨在为临床诊断、治疗、预后提供新的理论依据。方法:应用免疫组化法检测52例大肠癌组织、20例大肠腺瘤和20例大肠正常粘膜组织中Galectin-3的表达情况,分析其表达结果与患者的性别、年龄、肿瘤发生部位、肿瘤组织分化程度、浸润程度及淋巴结转移之间关系。实验资料的统计学处理通过SPSS13.0统计软件完成,等级资料采用秩和检验,以P<0.05为差异有统计学意义。结果:①Galectin-3在大肠正常黏膜、大肠腺瘤和大肠癌中均有阳性表达,表达强度依次增加,三组之间阳性表达率差异有统计学意义(P<0.01)。②Galectin-3在浸润程度深的大肠癌组织的表达明显高于浸润程度浅的(P<0.01);Galectin-3在低分化大肠癌中的表达则高于高分化和中等分化的(P<0.05);Galectin-3有淋巴结转移的大肠癌组织中的表达明显高于无淋巴结转移的(P<0.01)。Galectin-3在不同性别、年龄(≤60,>60)及肿瘤发生部位的表达则无明显差异(P>0.05)。结论:大肠癌组织中Galectin-3的表达水平明显高于正常大肠黏膜组织,提示Galectin-3的高表达在大肠癌的发生、发展过程中起到了重要的作用。Galectin-3在大肠癌不同浸润深度、不同分化程度及有无淋巴结转移中的表达有显著差异,提示上述指标在大肠癌的浸润、生长及远处播散过程中起到了一定的作用,并可作为判断大肠癌转移及预后的预测因素。 Objective:To study the expression of Galectin-3 in colorectal carcinoma , and to investigate its in colorectal cancer progression of meaning in the course , designed for clinical diagnosis , treatment , prog-nosis and provide a new theoretical basis .Method: Detected the expression of Galectin-3 in 52 cases of colorectal cancer , 20 cases of colorectal adenoma and 20 cases of colorectal normal mucosa tissue through the application of immunohistochemistry .Analyzed the relationship between its expression with the patient ’s sex, age, tumor location, tumor differentiation, infiltration and lymph node metastasi .Result: ①Galectin-3 in colorectal normal mucosa , colorectal adenoma and carcinoma showed positive expression , and the expression intensity increases , positive expression rate had a significant difference ( P〈0.01) among three groups .②Ga-lectin-3 in infiltration over the muscle layer of the colorectal carcinoma was higher than that of infiltration does not exceed the muscular layer of the colon cancer tissue ( P〈0.01);Galectin-3 in poorly differentiated colorectal carcinoma was higher than that of well-differentiated and moderately differentiated colorectal canc-er tissue ( P〈0.05 ); Galetctin-3 in lymph node metastasis of colorectal cancer tissues than those without lymph node metastasis in colorectal cancer tissue (P〈0.01).Conclusion: The expression of Galectin-3 in colorectal carcinoma is higher than that in normal colorectal mucosa .It suggests that the higher expression of Galectin-3 play an improtant role in the development of colorectal carcinoma .The expressions of Galectin-3 is significantly correlated with depth of invasion , lymph node metastasis and degree of differentiation in color-ectal carcinoma .So they could be a predictive and prognostic factor of colorectal carcinoma .
出处 《河北医学》 CAS 2014年第9期1421-1425,共5页 Hebei Medicine
基金 河北省承德市科学技术研究与发展计划项目 (编号:20132039)
关键词 大肠癌 半乳糖凝集素-3 免疫组织化学 Colorectal carcinoma Galectin-3 Immunohistochemisty
  • 相关文献

参考文献15

  • 1Jemal A, Thomas A, Murray T, et al.Cancer statistics [ J ]. CA Cancer J Clin,2013, 63(1) :11-30.
  • 2Saussez S, Camby I, Toubeau G, et al.Galectins as modulators of tumor progression in head and neck squamous cell carci- nomas [ J ].Head Neck, 2007,29 (9) : 874- 884.
  • 3Kim SJ, Choi U, Cheong TC, et al. Galectin- 3 increases gas- tric cancer cell motility by up-regulting fascin-1 expression [ J] .Gastroenterology, 2010,138 (3) : 1035-1045.
  • 4Barondes SH, Cooper DNW, Gitt MA, et al. Galectins : Struc- ture and function of a large family of animal lectins[J] .Biol Chem, 1994,269(33) :20807-20810.
  • 5Krzeslak A,Lipinska A.Galectin-3 as a muhifunctional pro- tein[J].Cell Mel Lett, 2004,9(2):305-328.
  • 6Nangia-Makker P, Honjo Y,Sarvis R,et al.Galectin-3 in- duces endothelial cell morphogenesis and angiogenesis [ J ]. Am Patho1,2000, 156(3) :899-909.
  • 7Nangia-Makker P, Raz T, et al.Galeetin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers [ J ]. Cancer Res, 2007, 67 ( 24 ) : 11760-11768.
  • 8Mook OR, Frederiks WM, Van Woorden CJ.The role of gela- tinases in oolorectal cancer progression and metastasis [ J ]. Bioehim Biophys Acta,2004,1705(2) :69-89.
  • 9Glinsky W, Glinsky GV, Rittenhouse - Olson K, et al. The role of Thomsen-Friedenreich antige in adhesion of human breast and prostate cancer cells to the endothelium [ J ]. Cancer Res,2001,61(12) :4851-4857.
  • 10Matarrese P, Fusco O, Tinari N, et al. Galectin- 3 overex- pretion profects from apoptosis by improving cell adhesion perties[ J] .Int Cancer,2000,85(4) :545-554.

二级参考文献21

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1370
  • 2Akahani S,Nangia-Makker P,Inohara H,et al.Galectin-3:a novel antiapoptotic molecule with a functional BHI (nwgr) domain of Bcl-2 family[J].Cancer Res,1997,57:5272-6.
  • 3Livak KJ,Schmittgen TD.Analysis of relative gene expression data using Real-Time Quantitative PCR and the -2 △△ CT method[J].Methods,2001,25:402-8.
  • 4Van Den Brule FA,Buicu C,Berchuck A,et al.Expression of the 67-kD laminin receptor,galectin-1,and galectin-3 in advanced human uterine adenocarcinoma[J].Hum Pathol,1996,27:1185-91.
  • 5Liu FT,Hsu DK,Zuberi RI,et al.Expression and function of galectin-3,a beta-galactoside-binding lectin,in human monocytes and macrophages[J].Am J Pathol,1995,147(4):1016-28.
  • 6Lotan R,Ito H,Yasui W,et al.Expression ofa 31-kDa lactosidebinding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas[J].Int J Cancer,1994,56(4):474-80.
  • 7Nagy N,Legendre H,Engels O,et al.Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting[J].Cancer,2003,97(8):1849-58.
  • 8Schoeppner HL,Raz A,Ho SB,et al.Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon[J].Cancer,1995,75(12):2818-26.
  • 9O'Driscoll L,Linehan R,M-Kennedy S,et al.Lack of prognostic significance of survivin,survivin-deltaEx3,surviving-2B,galectin-3,bag-1,bax-alpha and MRP-1 mRNAsin breast cancer[J].Cancer Lett,2003,201(2):225-36.
  • 10Ellerhorst JA,Stephens LC,Nguyen T,et al.Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP[J].Prostate,2002,50(1):64-70.

共引文献14

同被引文献24

  • 1Efstathios T Pavlidis,Theodoros E Pavlidis.Role of bevacizumab in colorectal cancer growth and its adverse effects:A review[J].World Journal of Gastroenterology,2013,19(31):5051-5060. 被引量:25
  • 2张楠,丁彦青,梁莉.Galectin-3在大肠癌组织中的表达及其临床意义[J].南方医科大学学报,2006,26(12):1685-1689. 被引量:15
  • 3Cherry LM. The genetic etiology of familial and nonfamilial colorec?tal cancer[J]. Proceedings (Baylor University. Medical Center),2011,24(2):139-141.
  • 4Argueso P, Mauris J, Uchino Y. Galectin-3 as a regulator of theepithelial junction: Implications to wound repair and cancer[J]. Tis?sue Barriers, 2015,3(3):e1026505.
  • 5Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Can?cer J Clin, 2015,65(1):5-29.
  • 6Bazensky I, Shoobridge-Moran C, Yoder LH. Colorectal cancer: anoverview of the epidemiology, risk factors, symptoms, and screen?ing guidelines[J]. Medsurg Nurs, 2007,16(1):46-51; quiz 52.
  • 7Giovannucci E. The epidemiology of vitamin D and colorectal can?cer: recent findings[J]. Curr Opin Gastroenterol, 2006,22(1):24-29.
  • 8Wang ZH, Fang JY. Colorectal Cancer in Inflammatory Bowel Dis?ease: Epidemiology, Pathogenesis and Surveillance[J]. GastrointestTumors, 2014,1(3):146-154.
  • 9Subhash VV, Ho B. Galectin 3 acts as an enhancer of survival re?sponses in H. pylori-infected gastric cancer cells[J]. Cell Biol Toxi?col, 2016,32(1):23-35.
  • 10Kuo HY, Hsu HT, Chen YC, et al. Galectin-3 modulates the EG?FR signalling-mediated regulation of Sox2 expression via c-Mycin lung cancer[J]. Glycobiology, 2016,26(2):155-165.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部